Clinical Trial Update: Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing anti-VEGF therapy to targeted retinal photocoagulation for macular perfusion changes in proliferative diabetic retinopathy; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Drugs mentioned

• anti-VEGF (vascular endothelial growth factor inhibitor)
• targeted retinal photocoagulation (retinal photocoagulation)

Snippet

Sponsor: Cairo University | Conditions: Proliferative Diabetic Retinopathy, Vascular Endothelial Growth Factor Overexpression | Phase 4 | Status: COMPLETED